BioMedical Enterprises
San Antonio
About BioMedical Enterprises
Biomedical Enterprises Inc. (BME) was founded to research, develop and commercialize medical products. BME's first product, an innovative dialysis needle (the BME needle), reduces patient complications resulting from hemodialysis, thereby increasing revenue for dialysis clinics and reducing cost for medical insurers. The BME needle provides a solution to the number one problem plaguing dialysis clinics, dialysis patients and insurers - clotting and occlusion of the vascular access. In addition, the BME needle appears to reduce inflammation and oxidative stress which also decrease the occurrence of medical complications. The company is raising funds to commercialize the needle and in the process of obtaining government approval for commercialization. The company has obtained about $1.0 million in grants from the U.S. National Institute of Health for R&D.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $862.9K
- Funding stage: M&A
- Last round: Series Unknown (Jun 2009)
- Website: bme-tx.com
- Phone: 2108810034
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/biomedical-enterprises-861133 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.